Groowe Groowe / Newsroom / AMRX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AMRX News

Amneal Pharmaceuticals, Inc. Class A Common Stock

Sodium Chloride Injections Market, Global Forecast 2026-2032 - Clinical Practice Migration and Manufacturing Modernization are Driving Innovations

globenewswire.com
AMRX ICUI PFE

Buprenorphine Patches Market Forecast Intelligence Report 2026-2032: Global, Regional and Country-Level Coverage

globenewswire.com
AMRX VRTS TEVA LPCN SUN

Topiramate Drugs Market - Global and Regional Trends, Drivers, and Growth Forecast 2026-2032 with Competition and Value Chain Analysis

globenewswire.com
AMRX JNJ TEVA

KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease

businesswire.com
AMRX

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

globenewswire.com
AMRX

Zambon Biotech annonce la première administration d'IPX203 à un patient dans le cadre de l'étude clinique ADIP de phase 3b dans la maladie de Parkinson

businesswire.com
AMRX

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease

businesswire.com
AMRX

Zambon Biotech annuncia l'arruolamento del primo paziente nello studio clinico di Fase 3b ADIP su IPX203 nella malattia di Parkinson

businesswire.com
AMRX

Zambon Biotech meldet erste Dosisverabreichung der klinischen Phase-3b-Studie ADIP zu IPX203 bei Parkinson

businesswire.com
AMRX

Food Preservatives Market Growth Outlook: CAGR of 4.7% and Value Reaching USD 5.01 Billion by 2032

globenewswire.com
AMRX